Home News & Events ICON survey highlights sustained investment in AI and digital R&D innovation, tempered by siloed adoption Read the press release ICON survey highlights scale of focus on precision therapies in increasingly complex oncology landscape Read the press release ICON recognised for leadership in clinical research and as socially responsible employer Read the press release Press releases 26 June 2023 ICON releases latest version of its Digital Platform 26 June 2023 ICON plc set to join Russell 3000® Index 31 May 2023 ICON plc to Attend Upcoming Investor Conferences 16 May 2023 ICON releases its 2022 ICON Cares ESG Report 26 April 2023 ICON reports first quarter 2023 results 29 March 2023 ICON plc Schedules First Quarter 2023 Earnings Conference Call 10 March 2023 LEO Pharma and ICON enter a strategic partnership to propel clinical trial execution within medical dermatology 27 February 2023 ICON plc to present at upcoming Investor Conferences 22 February 2023 ICON Reports Fourth Quarter and Full Year 2022 Results 26 January 2023 ICON plc Schedules Fourth Quarter 2022 Earnings Conference Call Events 17 January 2025 Pregnant participants in clinical trials Awards ICON Press office enquiries Videos Media articles What’s happening in ICON
